Dimensional Fund Advisors LP Cogent Biosciences, Inc. Transaction History

Dimensional Fund Advisors LP

$418 Billion
Q2 2025

A detailed history of Dimensional Fund Advisors LP transactions in Cogent Biosciences, Inc. stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 569,372 shares of COGT stock, worth $8.52 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

569,372

Previous 577,199 1.36%

Holding current value

$8.52 Million

Previous $3.46 Million 18.25%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 12, 2025	SELL	$4.02 - $7.51 $31,464 - $58,780	-7,827 Reduced 1.36%	569,372 $4.09 Million
Q1 2025 May 13, 2025	SELL	$5.99 - $9.66 $997,053 - $1.61 Million	-166,453 Reduced 22.38%	577,199 $3.46 Million
Q4 2024 Feb 13, 2025	SELL	$7.64 - $12.28 $372,610 - $598,907	-48,771 Reduced 6.15%	743,652 $5.8 Million
Q3 2024 Nov 07, 2024	SELL	$8.24 - $11.48 $1.14 Million - $1.58 Million	-137,874 Reduced 14.82%	792,423 $8.56 Million
Q2 2024 Aug 09, 2024	SELL	$6.01 - $9.04 $2.79 Million - $4.19 Million	-463,901 Reduced 33.27%	930,297 $7.84 Million
Q1 2024 May 10, 2024	SELL	$4.38 - $9.02 $1.06 Million - $2.19 Million	-242,636 Reduced 14.82%	1,394,198 $9.37 Million
Q4 2023 Feb 07, 2024	BUY	$4.06 - $10.08 $232,000 - $576,001	57,143 Added 3.62%	1,636,834 $9.62 Million
Q3 2023 Nov 09, 2023	BUY	$9.69 - $13.34 $4.48 Million - $6.17 Million	462,345 Added 41.38%	1,579,691 $15.4 Million
Q2 2023 Aug 09, 2023	BUY	$9.85 - $13.24 $2.84 Million - $3.82 Million	288,384 Added 34.79%	1,117,346 $13.2 Million
Q1 2023 May 12, 2023	BUY	$10.04 - $15.5 $3.64 Million - $5.63 Million	362,943 Added 77.88%	828,962 $8.94 Million
Q4 2022 Feb 09, 2023	BUY	$10.65 - $14.84 $4.2 Million - $5.85 Million	394,009 Added 547.16%	466,019 $5.39 Million
Q3 2022 Nov 10, 2022	SELL	$9.39 - $16.99 $13,700 - $24,788	-1,459 Reduced 1.99%	72,010 $1.07 Million
Q2 2022 Aug 12, 2022	BUY	$3.92 - $9.73 $8,020 - $19,907	2,046 Added 2.86%	73,469 $662,000
Q1 2022 May 13, 2022	BUY	$5.31 - $8.7 $150,920 - $247,271	28,422 Added 66.1%	71,423 $535,000
Q4 2021 Feb 09, 2022	BUY	$7.51 - $10.81 $322,937 - $464,840	43,001 New	43,001 $369,000

Others Institutions Holding COGT

# of Institutions

203

Shares Held

117M

Call Options Held

2.84M

Put Options Held

828K

View Full List

About Cogent Biosciences, Inc.

Ticker COGT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,758,300
Market Cap $984M
Description
Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies for genetically defined diseases. Its lead product candidate includes CGT9486, a selective tyrosine kinase inhibitor designed to inhibit the KIT D816V mutation that drives systemic mastocytosis, as well as other mutations in KIT exon 17, which are found ...

More about COGT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.

Account

Dimensional Fund Advisors LP Cogent Biosciences, Inc. Transaction History